Cxbladder Monitor is a Non-Invasive Urine Test for the Surveillance of Bladder Cancer

Cxbladder Monitor is a painless surveillance alternative that can reduce the burden of cystoscopy in those being monitored for recurrent non-muscle invasive bladder cancer.

Contact Us To Learn More
  • Accurate: Cxbladder is an advanced genomic test that delivers exceptional performance and meaningful results.
  • Clinically proven: The Cxbladder evidence portfolio includes more than 20 peer reviewed publications. Cxbladder has been used by over 4,400 US urologists in more than 100,000 patients.
  • Non-invasive and easy-to-use: Cxbladder's non-invasive urine sampling system is quick and easy to use, taking only minutes.
  • Quick: Upon receiving a urine sample, our certified laboratory will provide actionable results in 5 business days.

Bladder Cancer Patients have Unique Monitoring Needs

Patients that have been treated for non-invasive bladder cancer have unique monitoring needs to protect against the threat of recurrence. After assessing a patient’s risk profile, doctors will recommend a regular ongoing schedule of cystoscopies to examine the inside of the bladder and urethra.

If You’re Being Monitored for Bladder Cancer Recurrence, Ask Your Doctor About Cxbladder 

Cxbladder Monitor is a non-invasive alternative that can reduce the burden of cystoscopy in those being monitored for recurrent non-muscle invasive bladder cancer.

In suitable cases, a negative Cxbladder Monitor test result can safely postpone the need to undergo an invasive procedure.1

  • Following TURBT, Cxbladder Monitor can reduce the frequency of cystoscopy required to enhance comfort.​
  • When no recurrence has been detected after several years,  a Cxbladder Monitor test may provide an alternative to cystoscopy after consulting with your physician.​


Cxbladder Monitor comes with the option of in-home sampling to reduce the need for in-clinic visits.​

Contact us to learn more

1 Li K, Chu C, Patel M, Meng M, Morgan T, Porten S. Cxbladder Monitor testing to reduce cystoscopy frequency in patients with bladder cancer. Urol Oncol. 2023 Mar 1;S1078-1439(23)00009-1. doi: 10.1016/j.urolonc.2023.01.009  

Proven Performance

With proven performance in more than 20 peer-reviewed publications, Cxbladder is used by over 4,400 US urologists in more than 100,000 patients.

Multiple clinical trials have shown Cxbladder Monitor to be a highly accurate test for ruling out tumors. A study with data from over 1,100 US patient samples found that Cxbladder Monitor significantly outperforms current FDA-approved urine-based monitoring tests, including cytology and UroVysion FISH2. 

Browse Our Clinical Publications

2 Lotan Y, OʼSullivan P, Raman JD, Shariat SF, Kavalieris L, Frampton C, et al. Clinical comparison of non-invasive urine tests for ruling out recurrent urothelial carcinoma. Urologic Oncology: Seminars and Original Investigations. Elsevier; 2017;1–8.  

Non-Invasive and Easy-to-Use

Cxbladder’s unique urine sample collection system is non-invasive and easy-to-use, taking only minutes. Watch our instructions for use video to learn more. 

Greater Confidence in the Surveillance of Non-Muscle Invasive Bladder Cancer 

Cxbladder Monitor is a painless surveillance alternative that can reduce the burden of cystoscopy in those being monitored for recurrent non-muscle invasive bladder cancer.

Cxbladder provides reliable results with a single urine sample. In suitable cases this can safely postpone the need for patients to undergo an invasive procedure.

Call us - NZ: 0800-CXBLADR (0800-2925-237)

Contact us to learn more

Last Updated: 12 Jan 2024 04:05 pm